RSS   Newsletter   Contact   Advertise with us
Post Online Media

Bellicum Pharmaceuticals names Rick Fair as CEO

BellicumBellicum Pharmaceuticals, a clinical stage biopharmaceutical company, announced the appointment of Rick Fair as president and chief executive officer, and as a member of the board of directors.
Article continues below

READ MORE Bellicum appoints Alan K. Smith as SVP, manufacturing

Mr. Fair joins Bellicum from Genentech/Roche, where he was Senior Vice President, Head of Oncology Global Product Strategy.

Previously, Mr. Fair held several commercial leadership positions within Genentech, including franchise leadership with P&L responsibility for its thrombolytics and oral oncolytics businesses.

Prior to Genentech, he spent nine years in the pharmaceutical business at Johnson & Johnson, holding leadership roles in marketing, managed care and reimbursement strategy, and managed care customer management.

Mr. Fair holds a Bachelor of Science from the University of Michigan, and a Masters of Business Administration from Columbia Business School.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy